Join the Rheumatoid Arthritis group to help and get support from people like you.
Rheumatoid Arthritis News (Page 5)
Related terms: Arthritis, Arthritis, Rheumatoid, RA, Rheumatoid, Inflamed Joints
FDA approves Kineret for the treatment of NOMID
Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory ...
FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.” The pr...
FDA Approves Xeljanz for Rheumatoid Arthritis
November 6, 2012 – The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate...
Horizon Pharma Announces FDA Approval of Rayos (prednisone) Delayed-Release Tablets for Rheumatoid Arthritis and Multiple Additional Indications
DEERFIELD, Ill., July 26, 2012 /PRNewswire/ – Horizon Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Rayos (prednisone) delayed-release tablets (1 mg, 2...
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
PRINCETON, N.J.--(BUSINESS WIRE)--Jul 30, 2011 - Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) formulation of Orencia...
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
NORTHBROOK, IL--(Marketwire - Apr 25, 2011) - Horizon Pharma, Inc., a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis,...
FDA Grants Supplemental Approval for Actemra (tocilizumab)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan 5, 2011 - Genentech, Inc., a member of the Roche Group, today announced that the United States (U.S.) Food and Drug Administration (FDA) has extended...
FDA Approved Vimovo for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers
WILMINGTON, Del., April 30 /PRNewswire-FirstCall/ – AstraZeneca and Pozen Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Vimovo (naproxen and esomeprazole magnesium)...
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
BASEL, Switzerland, Jan. 11, 2010 - Roche today announced that the United States (US) Food and Drug Administration (FDA) approved Actemra (tocilizumab, RoActemra in the European Union) for the...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
prednisone, ibuprofen, naproxen, meloxicam, aspirin, doxycycline, Norco, diclofenac, methylprednisolone, view more... methotrexate, Vicodin, Humira, Celebrex, Aleve, Advil, Voltaren, triamcinolone, hydroxychloroquine, Plaquenil, cortisone, Motrin, Medrol, Enbrel, indomethacin, Remicade, Lortab, Mobic, Xeljanz, Rituxan, acetaminophen / hydrocodone, Arthritis Pain, adalimumab, Actemra, etanercept, dexamethasone, glucosamine, rituximab, nabumetone, tetracycline, garlic